Videos
Ruben Mesa, M.D., director of the UT Health San Antonio Cancer Center, discusses complementary therapy for patients with myeloproliferative neoplasms (MPNs).
Joshua Bauml, M.D., assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses the potential of therapeutic vaccine in patients who have head and neck cancer.
Advertisement
Advertisement
Trending on CURE
1
An Educational Overview of Newly Diagnosed Stage 1 Myelofibrosis
2
What Patients With AML Need to Know About Azacitidine and Venclexta
3
What Fatigue Feels Like for a Patient With Polycythemia Vera
4
Reflecting on My Sister’s Final Days After Years of Unexpected Rebounds
5
